MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

Veriheal

MARCH 1, 2022

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. What is Psilocybin?

Therapy 98

Therapy Programs Microdosing Medicine 98

MMJ Recs

APRIL 5, 2024

With cancer care, New York has emerged as a beacon of progress, offering patients access to a holistic approach that includes medical marijuana. With its therapeutic benefits increasingly recognized, medical cannabis has become an integral component of cancer treatment plans in the state.

Treatment 52

Treatment Marijuana Patients Therapy 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

MMJ Recs

APRIL 3, 2024

Understanding these regulations is crucial for patients, caregivers, and healthcare providers navigating the state’s medical marijuana program. Once approved, patients can register with the Ohio Medical Marijuana Control Program online and purchase medical marijuana products from licensed dispensaries statewide.

Law 52

Law Marijuana Conditions Patients 52

NORML

MAY 26, 2020

A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronic pain. Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 251

Clinical Trials Chronic Pain Cannabinoids Patients 251

Veriheal

FEBRUARY 14, 2024

The vote passed 7-0 after a group of senators, first responders, and military members held a press conference regarding the benefits and potential of psilocybin, also known as magic mushrooms , for mental health treatment. The goal is to ensure that psychedelic therapy remains safe, accessible, and affordable to those 21 and older.

Therapy 62

Therapy Legalization Research and Development Treatment 62

Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Behaviours and Health Risks Program, Burnet Institute, Melbourne, VIC 3004, Australia.

Medicine 59

Medicine Safety Policy Treatment 59

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

SEPTEMBER 25, 2023

With a growing recognition of its potential therapeutic benefits, Iowa has established a medical marijuana program to provide eligible patients with access to cannabis-based treatments. The Iowa medical marijuana program represents a significant step forward in providing patients with alternative treatment options.

Law 52

Law Chronic Pain Treatment Programs 52

MMJ Recs

NOVEMBER 10, 2023

As Missouri patients gain access to medical cannabis for various qualifying conditions, understanding and advocating for MMJ patient rights is of paramount importance. We’ll also explore patient rights and responsibilities within Missouri’s MMJ program and the availability of legal assistance for MMJ patients.

Advocacy 52

Advocacy Patients Legalization Access 52

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. goodblend™ Texas, a retail brand of Parallel.

Patients 97

Patients Programs Sleep Retail 97

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52

Safety Medicine Therapy Research and Development 52

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Various approaches, from strict medical programs to comprehensive recreational markets, highlight the diverse strategies adopted by states.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”

Law 259

Law Patients Access Oil 259

MMJ Recs

JANUARY 15, 2024

Today we’re here to tell you all you need to know about accessing and using medical marijuana in New Jersey! Governed by strict regulations, the program aims to provide patients with safe access to medicinal cannabis while maintaining a structured framework.

Chronic Pain 52

Chronic Pain Marijuana Programs Conditions 52

Cannabis Law Report

JUNE 12, 2021

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. Background. Conclusion.

Policy 66

Policy Safety Medicine Access 66

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Introduction. Search strategy.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

DECEMBER 5, 2021

Funders are endorsing MAPS’ mission and pursuit of mass mental health backed by 35 years of innovative leadership, governance, programs, and strategies. Getting MAPS out ahead of the industry will create a commercial and cultural bar that puts patient access first.”.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.

Dispensary 52

Dispensary Patients Marijuana Education 52

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

MMJ Recs

DECEMBER 13, 2023

Let’s take a look at the current state of medical marijuana dispensaries in Texas, examining the legal framework, patient access, and the potential impact on the healthcare landscape. While this was a positive development, the scope remained limited compared to other states with more comprehensive MMJ programs.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

MMJ Recs

NOVEMBER 6, 2023

As the state’s medical cannabis program continues to evolve, patients are presented with a diverse array of MMJ strains and products to explore. Medical Marijuana Products in New York New York’s medical cannabis program encompasses a wide range of products to meet the diverse needs of patients.

Strains 105

Strains Chronic Pain Patients Dispensary 105

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MMJ Recs

AUGUST 1, 2020

The accessibility of medical marijuana is an important issue for MMJ patients all over the country. In Oklahoma, accessibility has never been a problem since MMJ became legal in 2018. The state has one of the most liberal, open, and well-functioning MMJ programs in the country. Oklahoma Ban MMJ Delivery.

Access 59

Access Patients Dispensary Conditions 59

MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. This made the state a leader in the regulated cannabis industry, setting an example for others to follow.

Patients 52

Patients Law Cultivation Dispensary 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Additionally, stigma and misinformation surrounding medical marijuana persist, impacting public perception and patient access.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? NH resident? NH resident?

Legislation 243

Legislation Patients Decriminalization Access 243

MMJ Recs

JANUARY 20, 2024

Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

MMJ Recs

MARCH 12, 2024

Additionally, the Texas Department of Public Safety oversees the licensing of dispensaries and regulates the cultivation and distribution of medical marijuana. However, the law remains restrictive, limiting access to medical cannabis compared to other states.

Law 52

Law Compliance Compliance Policy 52

Cannabis Law Report

JANUARY 20, 2022

Emergency access to restricted drugs has been restored by recent regulatory amendments to Health Canada’s Special Access Program (SAP). SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient. Footnotes.

Access 52

Access Programs Treatment Therapy 52

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. These doses are produced under Good Agricultural and Collection Practices and tested for potency and impurities to support patient safety and practitioner confidence.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

MMJ Recs

OCTOBER 16, 2023

Accessing medical marijuana in Maryland has become more straightforward and convenient, thanks to the ability to obtain an MMJ card online. The state’s medical marijuana program allows patients to receive the treatment they need through a telemedicine evaluation, making it easier than ever to get an MMJ card.

Treatment 52

Treatment Conditions Chronic Pain History 52

NORML

JANUARY 19, 2020

House Bill 1359 would create a 5 year medical marijuana pilot program, allowing patients to access their medicine from licensed dispensaries. Send a message to your lawmakers in support of medical marijuana access. Legislation is pending, Senate Bill 697, to expand access to medical marijuana. IN resident? NH resident?

Legislation 246

Legislation Decriminalization Access Patients 246

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” The bill allocates $2 million for the grant program.

Legislation 97

Legislation Treatment Therapy Conditions 97